Enhanced Recovery at Cesarean Birth to Improve Postoperative Outcomes and Reduce Postoperative Length of Stay

• Status: Completed
• Trial end date: 2018-06-15
• Target enrollment: 0
• Participant gender: Female

Summary

To determine whether women randomized to an enhanced recovery program will have improved postoperative outcomes including improved breastfeeding initiation and continuation, reduction in hospital length of stay without compromising patient satisfaction in comparison to standard postoperative recovery interventions.

• Phase: Phase 2
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Montefiore Medical Center
• Treatments: Ketorolac

Criteria

Inclusion Criteria:

1. Women undergoing a non-urgent or elective cesarean delivery >37 weeks gestation

Exclusion Criteria:

1. Women undergoing an urgent or emergent cesarean birth

2. Women less than 18 years old

3. Patients receiving general anesthesia

4. Abnormally adherent placenta (Placenta Accreta) or expected excessive blood loss (Placenta accreta)

5. Pre-existing essential hypertension or hypertensive disorders of pregnancy (preeclampsia, eclampsia, HELLP)

6. Chronic or acute renal impairment

7. Bleeding disorders or platelet dysfunction

8. Peptic ulcer disease or gastrointestinal bleeding

9. Known hypersensitivity to ketorolac (toradol)

10. Active infection at the time of cesarean

11. Cesarean birth prior to 37 weeks

12. Women in significant pain in labor